Article Versions Notes

Kibel S, Kuehne N, Ribeiro MF, Muniz TP, Ye XY, Spreafico A, Saibil SD, Sun A, Mak DY, Gray D, et al. The Role of Adjuvant Radiotherapy for the Treatment of Resected High-Risk Stage III Cutaneous Melanoma in the Era of Modern Systemic Therapies. Cancers. 2023; 15(24):5867. https://doi.org/10.3390/cancers15245867

Kibel, Seth, Nathan Kuehne, Mauricio Fernando Ribeiro, Thiago P. Muniz, Xiang Y. Ye, Anna Spreafico, Samuel D. Saibil, Alexander Sun, David Y. Mak, Diana Gray, and et al. 2023. "The Role of Adjuvant Radiotherapy for the Treatment of Resected High-Risk Stage III Cutaneous Melanoma in the Era of Modern Systemic Therapies" Cancers 15, no. 24: 5867. https://doi.org/10.3390/cancers15245867

Kibel, S., Kuehne, N., Ribeiro, M. F., Muniz, T. P., Ye, X. Y., Spreafico, A., Saibil, S. D., Sun, A., Mak, D. Y., Gray, D., Jones, B., Wong, P., & Butler, M. O. (2023). The Role of Adjuvant Radiotherapy for the Treatment of Resected High-Risk Stage III Cutaneous Melanoma in the Era of Modern Systemic Therapies. Cancers, 15(24), 5867. https://doi.org/10.3390/cancers15245867